Molecular remission with arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia

George, B. ; Mathews, L. ; Balasubramanian, P. ; Shaji, R. V. ; Srivastava, A. ; Chandy, M. (2004) Molecular remission with arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia Haematologica, 89 (10). pp. 1266-1267. ISSN 1466-4860

[img]
Preview
PDF - Publisher Version
294kB

Official URL: http://www.haematologica.org/cgi/content/abstract/...

Abstract

Thirty six APML patients achieving hematological remission with As2O3 were serially monitored using RT-PCR. Though only 5.5% achieved molecular remission at induction remission, 94.5% became negative during consolidation. At 20 months follow-up, 85% remain in remission but longer follow up studies are needed to monitor late relapses.

Item Type:Article
Source:Copyright of this article belongs to European Hematology Association.
ID Code:5869
Deposited On:19 Oct 2010 10:25
Last Modified:16 May 2016 16:19

Repository Staff Only: item control page